These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22811982)

  • 1. Anthrax--where does the real threat lie?
    Senior K
    Lancet Infect Dis; 2012 Jun; 12(6):436-7. PubMed ID: 22811982
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioterrorism watch. Anthrax aftermath: adverse drug reactions, vaccine controversy undercut CDC extended treatment offer.
    Evans G
    Hosp Peer Rev; 2002 Mar; 27(3):suppl 1-4. PubMed ID: 11905387
    [No Abstract]   [Full Text] [Related]  

  • 3. Anthrax threat: a review of clinical and diagnostic measures.
    Alqurashi AM
    J Egypt Soc Parasitol; 2013 Apr; 43(1):147-66. PubMed ID: 23697023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The threat of bioterrorism.
    Berger DS
    Posit Aware; 2003; 14(2):40-1. PubMed ID: 12693375
    [No Abstract]   [Full Text] [Related]  

  • 5. Bioterrorism: what level is the threat and are vaccines the answer?
    Smith LA
    Expert Rev Vaccines; 2004 Oct; 3(5):493-5. PubMed ID: 15485326
    [No Abstract]   [Full Text] [Related]  

  • 6. Pediatric anthrax clinical management: executive summary.
    Bradley JS; Peacock G; Krug SE; Bower WA; Cohn AC; Meaney-Delman D; Pavia AT;
    Pediatrics; 2014 May; 133(5):940-2. PubMed ID: 24777221
    [No Abstract]   [Full Text] [Related]  

  • 7. Anthrax countermeasures: current status and future needs.
    Borio LL; Gronvall GK
    Biosecur Bioterror; 2005; 3(2):102-12. PubMed ID: 16000041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthrax prevention and treatment: utility of therapy combining antibiotic plus vaccine.
    Klinman DM; Yamamoto M; Tross D; Tomaru K
    Expert Opin Biol Ther; 2009 Dec; 9(12):1477-86. PubMed ID: 19769541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preattack vaccination against anthrax may be cost-effective in certain populations.
    Hopkins RJ; Waytes TA; Zink TK
    Arch Intern Med; 2008 Jan; 168(1):114-5; author reply 115. PubMed ID: 18195210
    [No Abstract]   [Full Text] [Related]  

  • 10. Responding to a small-scale bioterrorist anthrax attack: cost-effectiveness analysis comparing preattack vaccination with postattack antibiotic treatment and vaccination.
    Schmitt B; Dobrez D; Parada JP; Kyriacou DN; Golub RM; Sharma R; Bennett C
    Arch Intern Med; 2007 Apr; 167(7):655-62. PubMed ID: 17420423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines: countering anthrax: vaccines and immunoglobulins.
    Grabenstein JD
    Clin Infect Dis; 2008 Jan; 46(1):129-36. PubMed ID: 18171228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Learning from the 2001 anthrax attacks: immunological characteristics.
    Hadler JL
    J Infect Dis; 2007 Jan; 195(2):163-4. PubMed ID: 17191158
    [No Abstract]   [Full Text] [Related]  

  • 13. A mathematical simulation of the inflammatory response to anthrax infection.
    Kumar R; Chow CC; Bartels JD; Clermont G; Vodovotz Y
    Shock; 2008 Jan; 29(1):104-11. PubMed ID: 18157069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered chloroplasts as vaccine factories to combat bioterrorism.
    Streatfield SJ
    Trends Biotechnol; 2006 Aug; 24(8):339-42. PubMed ID: 16815579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioterrorism threat becomes reality.
    Ready T
    Nat Med; 2001 Nov; 7(11):1167. PubMed ID: 11689863
    [No Abstract]   [Full Text] [Related]  

  • 16. Anthrax as a biological weapon: an old disease that poses a new threat.
    Tasota FJ; Henker RA; Hoffman LA
    Crit Care Nurse; 2002 Oct; 22(5):21-32, 34; quiz 35-6. PubMed ID: 12382615
    [No Abstract]   [Full Text] [Related]  

  • 17. Guidelines for treatment of anthrax.
    Meyerhoff A; Murphy D
    JAMA; 2002 Oct; 288(15):1848-9; author reply 1848-9. PubMed ID: 12377082
    [No Abstract]   [Full Text] [Related]  

  • 18. Guidelines for treatment of anthrax.
    Tice AD
    JAMA; 2002 Oct; 288(15):1848; author reply 1848-9. PubMed ID: 12377080
    [No Abstract]   [Full Text] [Related]  

  • 19. US delays testing anthrax vaccine for children.
    Woodward C
    CMAJ; 2013 Jun; 185(9):E369-70. PubMed ID: 23589431
    [No Abstract]   [Full Text] [Related]  

  • 20. The development of new vaccines against Bacillus anthracis.
    Baillie L
    J Appl Microbiol; 2001 Oct; 91(4):609-13. PubMed ID: 11576296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.